This federal Project Grant award, titled "Adapting and Implementing Opioid-Sparing Pain Management Protocols Across Mount Sinai Health System Emergency Departments," is provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The $1,500,000 award will enable the Icahn School of Medicine at Mount Sinai to develop and implement...
The Ohio Department of Mental Health and Addiction Services (OhioMHAS) received a $400,907,000 Project Grant under CFDA 93.243 - Substance Abuse and Mental Health Services Projects of Regional and National Significance, awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA). The grant, titled "OHIO'S STATE OPIOID AND STIMULANT RESPONSE (SOS) 4.0 GRANT", aims to continue the state's efforts to address the opioid and stimulant crisis by expanding access to harm...
The Kettering Medical Center Network was awarded a $1,397,454 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant funding will be used to implement the PAUSE Pathway for Opioid Alternatives in the Emergency Department at Kettering Health's 14 emergency departments across 7 counties in western Ohio. Key components of the project...
This $63,202,996 Project Grant award, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243), supports a comprehensive 3-year initiative by the Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS) to address the opioid and stimulant misuse crisis in Oklahoma. The initiative focuses on prevention, harm reduction, treatment,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention to increase treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The key products and services to be delivered include: 1) a pilot feasibility study (R61 phase) of a...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $600,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the City of Altus, doing business as Altus Power, to address the opioid epidemic in the community. The project, titled "PROJECT VIOLET - BRIDGING THE GAPS; FIGHTING THE OPIOID EPIDEMIC HEAD ON, ONE PERSON AT A TIME," focuses on several key initiatives:...
This federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) provides $600,000 in funding to Michigan State University (MSU) and the University of Alabama (UAB) to implement a comprehensive addiction medicine education curriculum for medical students. The overarching goal is to provide robust education on the clinical, social,...
The Cuyahoga County Adult Drug Court Expansion Project is a $2,000,000 grant award over five years from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The project aims to expand the county's Adult Drug Court program to combat the opioid crisis in Ohio by enhancing services for participants with opioid use disorders. Key strategies include decreasing...
This federal Project Grant award for $630,000.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant's objective is to develop and refine a brief, digitally-enhanced psychotherapeutic intervention called "IMPROVE: Managing Physical Reactions to Overwhelming Emotions" to reduce alcohol use among individuals receiving medications for opioid use disorder (MOUD). The project will be conducted in two phases....
This $1,555,700 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program supports a comprehensive set of initiatives focused on addressing substance use disorders, mental health challenges, and health disparities in the southeastern United States. The primary awardee, the Morehouse School of Medicine, will provide evidence-based...
This $2,499,815 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will fund the "Emergency Department Alternatives to Opioids (ED-ALTO)" initiative at the University Hospitals Cleveland Medical Center (UHCMC) in Ohio.
The key objectives of this 3-year project are to: (1) increase ED provider knowledge on Medications for Opioid Use Disorder (MOUD) and Alternative to Opioids (ALTO) interventions; (2) implement evidence-based ALTO therapies such as acupuncture and music-assisted relaxation imagery in the UHCMC ED; and (3) disseminate best practices through publications and presentations. The overarching goal is to decrease opioid usage in the ED by promoting non-opioid pain management approaches. This aligns with SAMHSA's priority to address substance abuse treatment and prevention needs across the nation.